Advertisement

Autoimmune Dysfunction in Neurodevelopmental Disorders of Childhood

  • Abraham Weizman
  • Frank J. VocciJr.

Abstract

The syndrome of autism is characterized by a failure to develop normal age-appropriate social relationships, with disturbances of motor, social, adaptive, and cognitive abilities. Etiologic heterogeneity is assumed by most investigators because of the occurrence of autistic syndromes in persons with a variety of disorders (e.g., viral or genetic). As yet, no specific biochemical markers or deviations have been demonstrated. Abnormal responses to sensory stimuli (e.g., auditory, vestibular, visual, tactile, olfactory, and proprioceptive) have been described. Whether these features are due to emotional disturbances or to organic lesion is still controversial. Neurological syndromes such as phenylketonuria (PKU), hypsarrhythmia, and encephalitis caused by fetal rubella infection that may result in autistic features, as well as other brain dysfunctions, raise the possibility that autism is associated with an organic brain lesion(s). Extensive neurological examinations, including EEGs, demonstrated that signs of neurological dysfunction appear more frequently in autistic children than in normal children.1, 2 Damasio and Maurer3 suggested a neural bilateral dysfunction of the ring of mesolimbic cortex (located in the medial, frontal, and temporal lobes), the neostriatum, and the anterior and medial thalamic nuclei as a result of perinatal viral infection or genetically determined neurochemical abnormalities.

Keywords

Migration Inhibition Factor Myelin Basic Protein Autistic Child Autistic Patient Specific Biochemical Marker 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Knobloch H, Pasamanick B : Some etiologic and prognostic factors in early infantile autism and psychosis. Pediatrics 55:182–191, 1975PubMedGoogle Scholar
  2. 2.
    James AL, Barry RJ : A review of psychophysiology in early onset psychosis. Schizophr Bull 6:506–527, 1980PubMedGoogle Scholar
  3. 3.
    Damasio AR, Maurer RG : A neurological model for childhood autism. Arch Neurol 35:777–786, 1978PubMedCrossRefGoogle Scholar
  4. 4.
    Stubbs EG : Autistic children exhibit undetectable hemagglutination-inhibition antibody titers despite previous rubella vaccination. J Autism Dev Disord 6:269–274, 1976CrossRefGoogle Scholar
  5. 5.
    Stubbs EG, Crawford ML : Depressed lymphocyte responsiveness in autistic children. J Autism Dev Disord 7:49–55, 1977CrossRefGoogle Scholar
  6. 6.
    Warren RP, Margaretten NC, Pace NC : Immune abnormalities in patients with autism. J Autism Dev Disord 16:189–197, 1986PubMedCrossRefGoogle Scholar
  7. 7.
    Young JG, Caparulo BK, Shaywitz BA, et al : Childhood autism: Cerebrospinal fluid examination and immunoglobulin levels. J Child Psychiatry 16:174–179, 1977CrossRefGoogle Scholar
  8. 8.
    Warren RP, Foster A, Margaretten NC : Reduced natural killer cell activity in autism. J Am Acad Child Adol Psychol 3:333–335, 1987CrossRefGoogle Scholar
  9. 9.
    Goto M, Tanimoto K, Horiuchi Y : Natural cell-mediated cytotoxicity in systemic lupus erythematosus. Arthritis Rheum 23:1274–1281, 1980PubMedCrossRefGoogle Scholar
  10. 10.
    Waksman BH : Current trends in multiple sclerosis research. Immunol Today 2:87–93, 1981CrossRefGoogle Scholar
  11. 11.
    Goto M, Tanimoto K, Chihara T, et al : Natural cell-mediated cytotoxicity in Sjorgen’s syndrome and rheumatoid arthritis. Arthritis Rheum 24:1377–1382, 1981PubMedCrossRefGoogle Scholar
  12. 12.
    Ritvo ER, Yuwiler A, Geller E, et al : Increased blood serotonin and platelets in early infantile autism. Arch Gen Psychiatry 42:129–133, 1970Google Scholar
  13. 13.
    Weizman A, Weizman R, Szekely GA, et al : Abnormal immune response to brain tissue antigen in the syndrome of autism. Am J Psychiatry 139:1462–1465, 1982PubMedGoogle Scholar
  14. 14.
    Westall FC, Root-Bemstein RS : Suggested connection between autism, serotonin and myelin basic protein. Am J Psychiatry 140:1260–1261, 1983PubMedGoogle Scholar
  15. 15.
    Todd RD, Ciaranello RD : Demonstration of inter- and intraspecies differences in serotonin binding sites by antibodies from an autistic child. Proc Natl Acad Sci USA 82:612–616, 1985PubMedCrossRefGoogle Scholar
  16. 16.
    Todd RD, Hickok JM, Anderson GM, et al : Antibrain antibodies in infantile autism. Biol Psychiatry 23:644–647, 1988PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1990

Authors and Affiliations

  • Abraham Weizman
    • 1
    • 2
  • Frank J. VocciJr.
    • 3
  1. 1.Geha Psychiatric HospitalBeilinson Medical CenterPetah-TiqvaIsrael
  2. 2.Sackler Faculty of MedicineTel Aviv UniversityTel AvivIsrael
  3. 3.Medications Development Program, Division of Preclinical ResearchNational Institute on Drug AbuseRockvilleUSA

Personalised recommendations